Roche calls offer for Illumina "starting point"

April 11 (Reuters) - Swiss drugmaker Roche Holding AG, in a
letter to Illumina Inc shareholders, called its
sweetened $51-a-share offer for the maker of genetic analysis
equipment "a more than reasonable starting point for
negotiations."

drivers license renewal dmv permit test dmv driving test